The Exosome Therapeutics research team is developing a new therapeutic platform using stem cell nanoparticles called exosomes to treat neurological and cardiovascular diseases. These exosomes are small bubbles released by stem cells that heal damaged tissue. The Exosome Therapeutics team is engineering the therapeutic factors of these stem cell bubbles to uniquely address each type of neurological and cardiovascular disease. The initial pilot studies to demonstrate feasibility of this approach was funded by a prestigious high-risk, high-reward Transformative Research grant from the National Institutes of Health. We are now raising funds to complete this groundbreaking work and bring it into the preclinical stage for both neurological and cardiovascular diseases.